BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25540867)

  • 1. Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment.
    D'Angelo SP; Shoushtari AN; Agaram NP; Kuk D; Qin LX; Carvajal RD; Dickson MA; Gounder M; Keohan ML; Schwartz GK; Tap WD
    Hum Pathol; 2015 Mar; 46(3):357-65. PubMed ID: 25540867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic and Immunophenotypic Characterization of Tumor Immune Microenvironment in Squamous Cell Carcinoma of the Oral Tongue.
    Chatzopoulos K; Sotiriou S; Collins AR; Kartsidis P; Schmitt AC; Chen X; Khazaie K; Hinni ML; Ramsower CA; Zarka MA; Patel SH; Garcia JJ
    Head Neck Pathol; 2021 Jun; 15(2):509-522. PubMed ID: 33010009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement.
    Kemp Bohan PM; Chick RC; Hickerson AT; Messersmith LM; Williams GM; Cindass JL; Lombardo J; Collins R; Brady RO; Hale DF; Peoples GE; Vreeland TJ; Clifton GT
    Cancer Immunol Immunother; 2021 May; 70(5):1465-1474. PubMed ID: 33180182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune microenvironment of intimal sarcomas: Adaptive immune resistance with potential therapeutic implications.
    Birkness-Gartman JE; Thomas DL; Engle LL; Voltaggio L; Thompson ED
    Am J Clin Pathol; 2024 Mar; 161(3):256-263. PubMed ID: 37921094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of Tumour-Infiltrating Lymphocytes and Tumour-Associated Macrophages in Ovarian Epithelial Cancer-Relation to Tumour Characteristics and Impact on Prognosis.
    Stout A; Facey N; Bhatnagar A; Rice K; Berditchevski F; Kearns D; Metcalf A; Elghobashy A; Shaaban AM
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases.
    Steindl A; Alpar D; Heller G; Mair MJ; Gatterbauer B; Dieckmann K; Widhalm G; Hainfellner JA; Schmidinger M; Bock C; Müllauer L; Preusser M; Berghoff AS
    ESMO Open; 2021 Apr; 6(2):100057. PubMed ID: 33588158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, pathological, genetics and intratumoural immune milieu of micropapillary carcinoma of the colon.
    Deshpande V; Lee SH; Crabbe A; Pankaj A; Neyaz A; Ono Y; Rickelt S; Sonal S; Ferrone CR; Ting DT; Patil D; Yilmaz O; Berger D; Yilmaz O
    J Clin Pathol; 2024 May; 77(6):387-393. PubMed ID: 37258254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer.
    Lequerica-Fernández P; Rodríguez-Santamarta T; García-García E; Blanco-Lorenzo V; Torres-Rivas HE; Rodrigo JP; Suárez-Sánchez FJ; García-Pedrero JM; De Vicente JC
    Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37893049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune microenvironment of uterine adenosarcomas.
    Ali AMR; Tsai JW; Leung CH; Lin H; Ravi V; Conley AP; Lazar AJ; Wang WL; Nathenson MJ
    Clin Sarcoma Res; 2020; 10():5. PubMed ID: 32231779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study.
    Fay AP; Signoretti S; Callea M; Telό GH; McKay RR; Song J; Carvo I; Lampron ME; Kaymakcalan MD; Poli-de-Figueiredo CE; Bellmunt J; Hodi FS; Freeman GJ; Elfiky A; Choueiri TK
    J Immunother Cancer; 2015; 3():3. PubMed ID: 25767716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of liver tumor T cell infiltrates.
    Khan H; Pillarisetty VG; Katz SC
    J Surg Res; 2014 Sep; 191(1):189-95. PubMed ID: 25033707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The critical roles of lnc-GLYATL2-2/PD-L1 axis in immune microenvironment and the clinical value of intracranial chordomas.
    Wang C; Liu Y; Cui D; Jiang Y; Li L
    Am J Cancer Res; 2023; 13(12):6313-6332. PubMed ID: 38187065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma.
    Lenz JA; Assenmacher CA; Costa V; Louka K; Rau S; Keuler NS; Zhang PJ; Maki RG; Durham AC; Radaelli E; Atherton MJ
    Cancer Immunol Immunother; 2022 Apr; 71(4):807-818. PubMed ID: 34415404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.
    Keung EZ; Tsai JW; Ali AM; Cormier JN; Bishop AJ; Guadagnolo BA; Torres KE; Somaiah N; Hunt KK; Wargo JA; Lazar AJ; Wang WL; Roland CL
    Oncoimmunology; 2018; 7(2):e1385689. PubMed ID: 29308306
    [No Abstract]   [Full Text] [Related]  

  • 15. Correction to: Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.
    Curtis LT; Sebens S; Frieboes HB
    Cancer Immunol Immunother; 2021 May; 70(5):1489. PubMed ID: 33398392
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer.
    Phillips T; Simmons P; Inzunza HD; Cogswell J; Novotny J; Taylor C; Zhang X
    Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):541-9. PubMed ID: 26317305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapeutic approaches to sarcoma.
    Burgess M; Tawbi H
    Curr Treat Options Oncol; 2015 Jun; 16(6):26. PubMed ID: 25975445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Checkpoint inhibitors: An introduction to the next-generation cancer immunotherapy.
    Lee L; Gupta M; Sahasranaman S
    J Clin Pharmacol; 2016 Feb; 56(2):157-69. PubMed ID: 26183909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PD-L1 expression: An emerging biomarker in non-small cell lung cancer].
    Adam J; Planchard D; Marabelle A; Soria JC; Scoazec JY; Lantuéjoul S
    Ann Pathol; 2016 Jan; 36(1):94-102. PubMed ID: 26778219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classifying Cancers Based on T-cell Infiltration and PD-L1.
    Teng MW; Ngiow SF; Ribas A; Smyth MJ
    Cancer Res; 2015 Jun; 75(11):2139-45. PubMed ID: 25977340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.